Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 11/20 | 0.59 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.59 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.48 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.48 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.48 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8397422 | 0.97 | PTGS2 (0.55) | PTGS2PTGS1AKR1C2AKR1C1AKR1C3 | |
| SCHEMBL8104528 | 0.85 | PTGS2 (0.54) | PTGS2ESR2 | |
| SCHEMBL8103928 | 0.82 | PTGS2 (0.54) | PTGS2ESR2 | |
| SCHEMBL7807297 | 0.77 | PTGS2 (0.51) | PTGS2PTGS1AKR1C2AKR1C1AKR1C3 | |
| SCHEMBL444872 | 0.76 | PTGS2 (0.69) | PTGS2PTGS1 | |
| SCHEMBL4030635 | 0.75 | PTGS2 (0.62) | PTGS2PTGS1AKR1C2AKR1C1AKR1C3 | |
| SCHEMBL6050635 | 0.75 | CES2 (0.64) | PTGS2AKR1C2AKR1C1AKR1C3ESR2 | |
| SCHEMBL8392516 | 0.75 | PTGS2 (0.54) | PTGS2PTGS1AKR1C2AKR1C1AKR1C3 | |
| Sc-57666 SCHEMBL213008 | 0.75 | PTGS2 (1.00) | PTGS2PTGS1 | |
| SCHEMBL22252700 | 0.74 | ALDH1A1 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1682143-A2 | COMBINATIONS COMPRISING AN HSP90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA | Pharmacia Corporation (US) | 2006-07-26 | — | — | EP | disclosed |
| WO-2005044194-A2 | TREATMENT OR PREVENTION OF NEOPLASIA BY USE OF AN Hsp90 INHIBITOR | PHARMACIA CORPORATION (US) | 2005-05-19 | — | — | WO | disclosed |
| WO-2005041879-A2 | COMBINATIONS COMPRISING AN Hsp90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA | PHARMACIA CORPORATION (US) | 2005-05-12 | — | — | WO | disclosed |
| WO-2005041879-A2 | COMBINATIONS COMPRISING AN Hsp90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA | PHARMACIA CORPORATION (US) | 2005-05-12 | — | — | WO | disclosed |